REGENXBIO Inc. (RGNX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-mark

HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers t

Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and lowers the pr

Gainers Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular sess

US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jum

Regenxbio stock drops over 23% following an FDA clinical hold on its Hunter Syndrome gene therapy RG

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-ma

REGENXBIO Inc. (NASDAQ:RGNX) today provided an update on its investigational gene therapy, RGX-121 (

Wall Street analysts upgraded PTGX, LECO, and JHX. See analyst ratings and price targets for these s

HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers t

Wall Street analysts changed outlook on top names. For rating changes, check our analyst ratings pag

Top Wall Street analysts changed outlook on top names. For all changes & stock ratings, see anal

Barclays analyst Eliana Merle downgrades Regenxbio (NASDAQ:RGNX) from Overweight to Equal-Weight

Regenxbio (NASDAQ:RGNX) reported quarterly earnings of $0.43 per share which beat the analyst consen

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin

REGENXBIO announced positive long-term sura-vec trial data for wet AMD and diabetic retinopathy, alo

Nasdaq falls over 200 points, Dow down 0.28%, S&P 500 drops 0.51%. Energy shares up 1.4%, commun

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s

U.S. stock futures lower, Nasdaq 100 down 2%. Intuitive Surgical shares dip 11.3% after Q2 earnings

NFLX: 10% | Netflix shares are trading lower after the company reported worse-than-expected Q2 sales

The gross proceeds to REGENXBIO from the offering, before deducting the underwriting discounts and c

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

REGENXBIO Inc. (NASDAQ:RGNX) today announced that it intends to offer and sell, subject to market co

New long-term data from diabetic retinopathy and wet AMD programs to be presented at American Societ

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

HC Wainwright & Co. analyst Yi Chen reiterates Regenxbio (NASDAQ:RGNX) with a Buy and maintai

Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator

Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and raises the pr

Leerink Partners analyst Mani Foroohar maintains Regenxbio (NASDAQ:RGNX) with a Outperform and ra

FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy ap

REGENXBIO Inc. (NASDAQ:RGNX) today announced it has aligned with the U.S. Food and Drug Administrati

SAGT: 124% | Sagtec Global CEO's 1.5M Share Acquisition And $1.56M Private Placement Coincide Wi

US stocks up, Dow gains 250+ pts. Tech sector up 0.8%, healthcare down 0.3%. Retail sales rise 0.5%

Nancy Pelosi Stock Tracker highlighted Claude AI's Denali Therapeutics earnings bet, which targe

Denali Therapeutic snags FDA accelerated approval for Avlayah for Hunter syndrome, analyst flags str

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer

REGENXBIO shares fall after the FDA issues a response letter on its Hunter syndrome gene therapy, ra